Annual Shareholders Equity
$19.25 M
-$17.39 M-47.47%
December 31, 2023
Summary
- As of March 13, 2025, MTNB annual stockholders equity is $19.25 million, with the most recent change of -$17.39 million (-47.47%) on December 31, 2023.
- During the last 3 years, MTNB annual shareholders equity has fallen by -$44.48 million (-69.80%).
- MTNB annual shareholders equity is now -69.80% below its all-time high of $63.73 million, reached on December 31, 2020.
Performance
MTNB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$15.78 M
-$3.32 M-17.40%
September 30, 2024
Summary
- As of March 13, 2025, MTNB quarterly stockholders equity is $15.78 million, with the most recent change of -$3.32 million (-17.40%) on September 30, 2024.
- Over the past year, MTNB quarterly shareholders equity has dropped by -$7.37 million (-31.84%).
- MTNB quarterly shareholders equity is now -79.67% below its all-time high of $77.60 million, reached on March 31, 2020.
Performance
MTNB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
MTNB Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.5% | -31.8% |
| 3 y3 years | -69.8% | -31.8% |
| 5 y5 years | +19.2% | -31.8% |
MTNB Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.3% | at low | -69.9% | +8.4% |
| 5 y | 5-year | -69.8% | at low | -79.7% | +8.4% |
| alltime | all time | -69.8% | +763.9% | -79.7% | +608.3% |
Matinas BioPharma Holdings Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.78 M(-17.4%) |
| Jun 2024 | - | $19.10 M(+31.2%) |
| Mar 2024 | - | $14.56 M(-24.4%) |
| Dec 2023 | $19.25 M(-47.5%) | $19.25 M(-16.9%) |
| Sep 2023 | - | $23.15 M(-16.9%) |
| Jun 2023 | - | $27.85 M(-14.6%) |
| Mar 2023 | - | $32.63 M(-11.0%) |
| Dec 2022 | $36.64 M(-30.2%) | $36.64 M(-5.1%) |
| Sep 2022 | - | $38.62 M(-9.9%) |
| Jun 2022 | - | $42.85 M(-10.1%) |
| Mar 2022 | - | $47.68 M(-9.2%) |
| Dec 2021 | $52.49 M(-17.6%) | $52.49 M(-9.9%) |
| Sep 2021 | - | $58.25 M(-7.4%) |
| Jun 2021 | - | $62.90 M(-5.5%) |
| Mar 2021 | - | $66.56 M(+4.4%) |
| Dec 2020 | $63.73 M(+92.8%) | $63.73 M(-6.6%) |
| Sep 2020 | - | $68.21 M(-6.3%) |
| Jun 2020 | - | $72.82 M(-6.2%) |
| Mar 2020 | - | $77.60 M(+134.8%) |
| Dec 2019 | $33.05 M | $33.05 M(-13.0%) |
| Sep 2019 | - | $37.98 M(-6.0%) |
| Jun 2019 | - | $40.42 M(-6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $43.01 M(+166.4%) |
| Dec 2018 | $16.14 M(+51.1%) | $16.14 M(+56.7%) |
| Sep 2018 | - | $10.30 M(-17.8%) |
| Jun 2018 | - | $12.53 M(+48.5%) |
| Mar 2018 | - | $8.43 M(-21.0%) |
| Dec 2017 | $10.68 M(+49.4%) | $10.68 M(-16.4%) |
| Sep 2017 | - | $12.78 M(-15.9%) |
| Jun 2017 | - | $15.21 M(-19.4%) |
| Mar 2017 | - | $18.86 M(+163.8%) |
| Dec 2016 | $7.15 M(+17.7%) | $7.15 M(-18.0%) |
| Sep 2016 | - | $8.72 M(+191.0%) |
| Jun 2016 | - | $3.00 M(-29.0%) |
| Mar 2016 | - | $4.22 M(-30.5%) |
| Dec 2015 | $6.07 M(+172.6%) | $6.07 M(-12.8%) |
| Sep 2015 | - | $6.96 M(-19.3%) |
| Jun 2015 | - | $8.63 M(+35.0%) |
| Mar 2015 | - | $6.39 M(+186.9%) |
| Dec 2014 | $2.23 M(-78.7%) | $2.23 M(-53.1%) |
| Sep 2014 | - | $4.75 M(-26.5%) |
| Jun 2014 | - | $6.46 M(-25.0%) |
| Mar 2014 | - | $8.61 M(-17.8%) |
| Dec 2013 | $10.47 M | $10.47 M |
FAQ
- What is Matinas BioPharma Holdings annual stockholders equity?
- What is the all time high annual shareholders equity for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual shareholders equity year-on-year change?
- What is Matinas BioPharma Holdings quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly shareholders equity year-on-year change?
What is Matinas BioPharma Holdings annual stockholders equity?
The current annual shareholders equity of MTNB is $19.25 M
What is the all time high annual shareholders equity for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual stockholders equity is $63.73 M
What is Matinas BioPharma Holdings annual shareholders equity year-on-year change?
Over the past year, MTNB annual stockholders equity has changed by -$17.39 M (-47.47%)
What is Matinas BioPharma Holdings quarterly stockholders equity?
The current quarterly shareholders equity of MTNB is $15.78 M
What is the all time high quarterly shareholders equity for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly stockholders equity is $77.60 M
What is Matinas BioPharma Holdings quarterly shareholders equity year-on-year change?
Over the past year, MTNB quarterly stockholders equity has changed by -$7.37 M (-31.84%)